Christy J. Oliger
CIK 1822092 · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$636.8K
Companies
8
Total Filings
27
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERA | Director | — | $34.26 | — | $0 | 3 | 2026-05-26 |
| KPTI | Director | 15,508 | $9.50 | $147.3K | $0 | 7 | 2026-05-26 |
| REPL | Director | — | $8.88 | — | $0 | 6 | 2026-04-07 |
| LAVA Therapeutics NV (LVTX) Delisted | Director | — | $1.74 | — | $0 | 2 | 2025-11-17 |
| NUVL | Director | 3,971 | $123.25 | $489.4K | $0 | 1 | 2025-06-20 |
| RayzeBio, Inc. (RYZB) Delisted | Director | — | $62.49 | — | $0 | 1 | 2024-02-27 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Director | 0 | $172.36 | $0 | $0 | 5 | 2023-09-26 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | — | $54.99 | — | $0 | 2 | 2022-07-01 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-30 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2024-04-03 | REPL | Grant (A) | — | $0 | EDGAR |
| 2024-02-27 | RayzeBio, Inc. (RYZB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-09-26 | REATA PHARMACEUTICALS INC (RETA) Delisted | Disp (D) | −5,565 | $0 | EDGAR |
| 2023-06-09 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +1,682 | $157.5K | EDGAR |
| 2023-05-25 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | REPL | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | Sierra Oncology, Inc. (SRRA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-06-09 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +3,883 | $135.0K | EDGAR |
| 2022-05-20 | KPTI | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.